|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.210 USD | -1.23% |
|
+1.69% | -47.41% |
| Nov. 26 | Sector Update: Health Care Stocks Edge Higher Premarket Wednesday | MT |
| Nov. 25 | Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 8.18 | 8.18 | 14.83 |
| Spread/Res. | -11.86% | -11.86% | -51.38% |
| Spread/Supp. | +14.44% | +30.85% | +85.35% |
| Support | 6.3 | 5.51 | 3.89 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
